Literature DB >> 9807570

Choledocholithiasis: evaluation of MR cholangiography for diagnosis.

C Reinhold1, P Taourel, P M Bret, G A Cortas, S N Mehta, A N Barkun, L Wang, F Tafazoli.   

Abstract

PURPOSE: To evaluate the test performance of magnetic resonance (MR) cholangiography for help in diagnosing choledocholithiasis.
MATERIALS AND METHODS: Fast spin-echo MR cholangiography was performed by using a torso multicoil array in 110 patients suspected of having bile duct obstruction. Axial and coronal images were reviewed by two observers who were blinded to results of direct cholangiography and final diagnoses. The final diagnosis was established by using direct cholangiographic (n = 103) or surgical (n = 7) findings.
RESULTS: Of the 110 patients, 30 (27%) had choledocholithiasis, and 80 (73%) did not. Reviewer 1 used MR cholangiograms to achieve a sensitivity of 90%, specificity of 100%, positive predictive value of 100%, negative predictive value of 96%, and overall accuracy of 97%. Reviewer 2 achieved a sensitivity of 90%, specificity of 93%, positive predictive value of 82%, negative predictive value of 96%, and overall accuracy of 92%. Interobserver agreement for MR cholangiograms was 93% (kappa = 0.82).
CONCLUSION: MR cholangiography exhibited excellent test performance and resulted in excellent interobserver agreement for the diagnosis of choledocholithiasis.

Entities:  

Mesh:

Year:  1998        PMID: 9807570     DOI: 10.1148/radiology.209.2.9807570

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  18 in total

1.  Helical computed tomographic cholangiography versus endosonography for suspected bile duct stones: a prospective blinded study in non-jaundiced patients.

Authors:  M Polkowski; J Palucki; J Regula; A Tilszer; E Butruk
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

2.  Common bile duct stones: magnetic resonance cholangiopancreatography vs. endoscopic retrograde cholangiopancreatography for detection.

Authors:  A N Barkum
Journal:  J Gastrointest Surg       Date:  2000 Jul-Aug       Impact factor: 3.452

Review 3.  Early endoscopic management of acute gallstone pancreatitis--an evidence-based review.

Authors:  A N Barkun
Journal:  J Gastrointest Surg       Date:  2001 May-Jun       Impact factor: 3.452

Review 4.  The role of magnetic resonance cholangiopancreatography in patients with suspected biliary obstruction.

Authors:  Mannudeep Kalra; Dushyant Sahani; Aamir Ahmad; Sanjay Saini
Journal:  Curr Gastroenterol Rep       Date:  2002-04

5.  Choledocholithiasis: repetitive thick-slab single-shot projection magnetic resonance cholangiopancreaticography versus endoscopic ultrasonography.

Authors:  S Schmidt; P Chevallier; S Novellas; E Gelsi; G Vanbiervliet; A Tran; P Schnyder; J N Bruneton
Journal:  Eur Radiol       Date:  2006-08-29       Impact factor: 5.315

6.  Gallbladder wall thickening: MR imaging and pathologic correlation with emphasis on layered pattern.

Authors:  S E Jung; J M Lee; K Lee; S E Rha; B G Choi; E K Kim; S T Hahn
Journal:  Eur Radiol       Date:  2004-11-24       Impact factor: 5.315

7.  Postprocedural interpretation of endoscopic retrograde cholangiopancreatography by radiology.

Authors:  Nitin Khanna; Gary May; Sydney Bass; Marty Cole; Joseph Romagnuolo
Journal:  Can J Gastroenterol       Date:  2008-01       Impact factor: 3.522

8.  The Value of Magnetic Resonance Cholangio-Pancreatography (MRCP) in the Detection of Choledocholithiasis.

Authors:  Ankur Mandelia; Arun Kumar Gupta; Devendra Kumar Verma; Sanjeev Sharma
Journal:  J Clin Diagn Res       Date:  2013-09-10

9.  Common bile duct stones - their presentation, diagnosis and management.

Authors:  Rajendra Desai; Bahaman N Shokouhi
Journal:  Indian J Surg       Date:  2009-09-02       Impact factor: 0.656

10.  The role of magnetic resonance cholangiopancreatography in the management of acute gallstone pancreatitis.

Authors:  A D Barlow; J Haqq; D McCormack; M S Metcalfe; A R Dennison; G Garcea
Journal:  Ann R Coll Surg Engl       Date:  2013-10       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.